Prot# 34976: A 12-Month Follow-Up Study to Protocol 24779 (A Double-Blind, Prospective, Randomized, Placebo-Controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells

Project: Research project

Project Details

StatusFinished
Effective start/end date11/26/0811/25/11

Funding

  • United BioSource LLC (34976 // 34976)
  • Baxter Healthcare Corporation (34976 // 34976)